Sotagliflozin, CAS 1018899-04-1

Product Description: Sotagliflozin (LX-4211) is a potent dual SGLT2/1 inhibitor. Antidiabetic agents.

Applications: Metabolism-sugar/lipid metabolism

Formula: C21H25ClO5S

References: [1]Zambrowicz B, et al. LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther. 2012 Aug;92(2):158-69./[2]Powell DR, et al. LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther. 2013 May;345(2):250-9.

CAS Number: 1018899-04-1

Molecular Weight: 424.94

Compound Purity: 99.94

Research Area: Metabolic Disease

Solubility: DMSO : ≥ 100 mg/mL

Target: SGLT

• SKU: MEXHY-15516-10.1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-15516-10.1
• Package Unit: 10 mM/1 ml
• Quantity Unit: STK